𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease

✍ Scribed by Yu-Wen Huang; Jiann-Shing Jeng; Chung-Fen Tsai; Li-Ling Chen; Ruey-Meei Wu


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
117 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Transcranial Doppler imaging (TCDI) has been used as a noninvasive diagnostic tool to differentiate Parkinson's disease (PD) from atypical parkinsonism by detecting hyperechogenicity in the substantia nigra (SN). To our knowledge, no TCDI data are available for Asian populations, and TCDI sensitivity is uncertain across populations. Early‐onset PD (EOPD) represents a specific PD subtype based on clinical features and pathogenic mechanisms. It is not known if EOPD patients have abnormal echogenicity in SN comparable to late‐onset PD (LOPD) patients. We assessed the area of SN hyperechogenicity (hyper‐SN) and a ratio of hyper‐SN over ipsilateral midbrain (S/M ratio) with TCDI in 164 healthy Taiwanese, 40 EOPD patients, and 40 LOPD patients. The upper 95th percentile values for hyper‐SN and S/M ratio were 0.20 cm^2^ and 0.07. Our results indicate that S/M ratio is a more sensitive measure than hyper‐SN in diagnosing PD. Approximately 92.5% of the LOPD patients and 57.5% of the EOPD patients had S/M ratios ≥ 0.07. Enlarged hyperechogenicity of SN is a common finding in LOPD, but not in EOPD. Iron‐independent mechanisms of SN cell degeneration in EOPD distinct from that in LOPD might contribute to the sonographic findings. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Substantia nigra hyperechogenicity as a
✍ Katherine J. Schweitzer; Rüdiger Hilker; Uwe Walter; Lothar Burghaus; Daniela Be 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound mar

Five-year follow-up study of hyperechoge
✍ Daniela Berg; Berthold Merz; Karlheinz Reiners; Markus Naumann; Georg Becker 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

## Abstract Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, w

High resolution magnetic susceptibility
✍ Ashley K. Lotfipour; Samuel Wharton; Stefan T. Schwarz; V. Gontu; Andreas Schäfe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract ## Purpose: To determine if tissue magnetic susceptibility is a more direct marker of tissue iron content than other MR markers of iron. This study presents the first quantitative, in vivo measurements of the susceptibility of the substantia nigra in patients with Parkinson's disease.

Substantia nigra echogenicity: A structu
✍ David Weise; Reinhard Lorenz; Mira Schliesser; Andreas Schirbel; Karlheinz Reine 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

## Abstract Transcranial sonography (TCS) reveals abnormal spatial extension of substantia nigra (SN) echogenicity in a high proportion of patients with Parkinson's disease (PD). It has been proposed that this abnormality represents a structural trait that is mechanistically distinct from degenerat

Raman microspectroscopy of the brain tis
✍ C. W. Ong; Z. X. Shen; Y. He; T. Lee; S. H. Tang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

The substantia nigra of the rostral mid-brain of a monkey was studied using Raman microspectroscopy. The white and grey matter could be clearly distinguished and their relative proportions evaluated from the Raman peaks in the 3000 cm-1 region. Raman spectra obtained from the substantia nigra for bo

Lack of G2019S LRRK2 mutation in a cohor
✍ Hon-Chung Fung; Chiung-Mei Chen; John Hardy; Dena Hernandez; Andrew Singleton; Y 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

## Abstract Mutations in the leucine‐rich repeat kinase 2 (__LRRK2__) gene have been shown to cause autosomal dominant and sporadic Parkinson's disease (PD). We report here the frequency of a common heterozygous mutation, 2877510G>A, which produces a glycine‐to‐serine amino acid substitution at cod